CD40LG and neoplasm: Curiously, the increased proliferation in all tumor-resident cDC subsets did not result in an increase in absolute cDC numbers after CD40L-CAR T cell treatment (Fig. 1b), suggesting that the proliferating tumor-resident cDCs migrate out of the tissue to lymphoid structures, where they are present at higher numbers (Fig. 1c, e).